Description: Cardiac amyloidosis, once considered a rare and untreatable disorder, is now recognized as an important and often overlooked cause of restrictive cardiomyopathy. This presentation explores the pathophysiology, diagnosis, and classification of amyloidosis with a focused review on transthyretin (ATTR) cardiac amyloidosis. Attendees will gain an understanding of emerging diagnostic strategies, current and investigational therapies—including TTR stabilizers and gene silencers—and key evidence guiding modern management.

Microsoft Teams Webinar link to register for the live session: Register Here

Speaker: Kaitlin Mooney, PharmD, PGY2 Cardiology Pharmacy Resident – Atrium Health Wake Forest Baptist Medical Center

Objectives: ​​ 

  1. Recognize transthyretin cardiac amyloidosis and its underlying pathophysiology.
  2. Identify different diagnostic criteria for ATTR cardiac amyloidosis.
  3. Describe current and emerging therapies for ATTR cardiac amyloidosis.
  4. Recall key clinical evidence supporting disease-modifying therapies.

Target Audience:​ Advocate Pharmacists, Physicians, Nurses, and other interested healthcare professionals

Disclosure:​ The planner(s) and speaker(s) have indicated that there are no relevant financial relationships with any ineligible companies to disclose. 

Materials: PDF icon Single Activity Flyer LIVE- Mooney.pdf

Pharmacist UAN: JA0006327-0000-26-001-L01-P

Session date: 
01/29/2026 - 12:00pm to 1:00pm CST
Location: 
Reynolds Tower-Penthouse Conference Room 1 and Virtual via Teams
United States
  • 1.00 AMA PRA Category 1 Credit™
    Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
    Attendance Credit
    • 1.00 Approved AMA PRA Category 1 Credit™
  • 1.00 Continuing Nursing Education (CE)
    Aurora Health Care is an approved provider of continuing nursing education by the Wisconsin Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. 1.00 contact hours have been awarded to this activity by the Wisconsin Nursing Association. To receive contact hours, participants must attend the entire activity.
    • 1.00 APRN Pharmacotherapeutic Contact Hours
  • 1.00 Continuing Pharmacy Education (CPE)
    Aurora Health Care Department of Pharmacy Services is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Please login or register to take this course.